Abstract
Metastatic intrathyroid thymic carcinoma (ITTC) is a rare cancer with no effective drugs for controlling. This case report has shown genomic and immune microenvironment profiles in metastatic ITTC and emphasized an immunosuppression via a PD‐1/PD‐L1 pathway, possibly strengthening the rationale for immune checkpoint blockade as a novel treatment.
Cite
CITATION STYLE
APA
Ishii, H., Tsujikawa, T., Oishi, N., Kinouchi, A., Sakamoto, K., Mitsuda, J., … Sakurai, D. (2022). Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma. Clinical Case Reports, 10(7). https://doi.org/10.1002/ccr3.6050
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free